122 related articles for article (PubMed ID: 21293143)
1. Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract--a new therapeutic option for patients with atopic dermatitis.
Novak N; Thaci D; Hoffmann M; Fölster-Holst R; Biedermann T; Homey B; Schaekel K; Stefan JA; Werfel T; Bieber T; Sager A; Zuberbier T
Int Arch Allergy Immunol; 2011; 155(3):252-6. PubMed ID: 21293143
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety, and immunological effects of a 2-year immunotherapy with Depigoid birch pollen extract: a randomized, double-blind, placebo-controlled study.
Höiby AS; Strand V; Robinson DS; Sager A; Rak S
Clin Exp Allergy; 2010 Jul; 40(7):1062-70. PubMed ID: 20642579
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects.
Ceuppens JL; Bullens D; Kleinjans H; van der Werf J;
Clin Exp Allergy; 2009 Dec; 39(12):1903-9. PubMed ID: 20085600
[TBL] [Abstract][Full Text] [Related]
4. Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients.
Pfaar O; Biedermann T; Klimek L; Sager A; Robinson DS
Allergy; 2013 Oct; 68(10):1306-13. PubMed ID: 23991896
[TBL] [Abstract][Full Text] [Related]
5. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J
Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
[TBL] [Abstract][Full Text] [Related]
7. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
8. Specific immunotherapy in atopic dermatitis--Four-year treatment in different age and airborne allergy type subgroups.
Czarnecka-Operacz M; Silny W
Acta Dermatovenerol Croat; 2006; 14(4):230-240. PubMed ID: 17328144
[TBL] [Abstract][Full Text] [Related]
9. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut.
Bucher X; Pichler WJ; Dahinden CA; Helbling A
Allergy; 2004 Dec; 59(12):1272-6. PubMed ID: 15507095
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects.
Kopp MV; Stenglein S; Kamin W; Friedrichs F; von Berg A; Zielen S; Hamelmann E; Wahn U; Kuehr J
Pediatr Allergy Immunol; 2007 Sep; 18(6):523-7. PubMed ID: 17680911
[TBL] [Abstract][Full Text] [Related]
11. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
Rak S; Heinrich C; Scheynius A
Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
[TBL] [Abstract][Full Text] [Related]
12. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
13. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy.
Alonso R; Enrique E; Pineda F; Basagaña M; San Miguel-Moncín MM; Bartra J; Palacios R; Cisteró-Bahíma A
Int Arch Allergy Immunol; 2007; 143(3):185-9. PubMed ID: 17284927
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of injection immunotherapy with ragweed and birch pollen in elderly patients.
Asero R
Int Arch Allergy Immunol; 2004 Dec; 135(4):332-5. PubMed ID: 15564775
[TBL] [Abstract][Full Text] [Related]
16. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
Kawakami A; Koketsu R; Suzukawa M; Nagao M; Hiraguchi Y; Tokuda R; Fujisawa T; Nagase H; Ohta K; Yamamoto K; Yamaguchi M
Int Arch Allergy Immunol; 2008; 146 Suppl 1():54-60. PubMed ID: 18504408
[TBL] [Abstract][Full Text] [Related]
17. Food allergy to apple and specific immunotherapy with birch pollen.
Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ
Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life.
Alvarez-Cuesta E; Aragoneses-Gilsanz E; Martín-Garcia C; Berges-Gimeno P; Gonzalez-Mancebo E; Cuesta-Herranz J
Clin Exp Allergy; 2005 May; 35(5):572-8. PubMed ID: 15898977
[TBL] [Abstract][Full Text] [Related]
19. [Development of new sensitizations to allergic components in birch pollen extract during specific immunotherapy].
Modrzyński M; Zawisza E
Przegl Lek; 2003; 60(3):130-2. PubMed ID: 14575011
[TBL] [Abstract][Full Text] [Related]
20. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
